#vitreoretinalsurgeon and #uveitis specialist @ucd_eyecenter |
Joined March 2021
- Tweets78
- Following210
- Followers361
- Likes653
Parisa Emami, MD, MPH retweeted
Case control study of 80 eyes from patients with autism and 160 from neurotypical controls found inner retina thicker in #autism and correlates with brain volumes #OCT #MRI @ParisaEmamiMD @FatemeMonta3eri @ucdavis
ow.ly/iCFz50W6jit
Parisa Emami, MD, MPH retweeted
New study highlights racial disparities in healthcare access & quality for patients with #uveitis using the @NIH All of Us Database. Check out the study for more details. @FatemeMonta3eri @ParisaEmamiMD
ow.ly/wMbL50UMw52
Parisa Emami, MD, MPH retweeted
Parisa Emami-Naeini, MD, MPH, is our final One to Watch of 2024! She is an associate professor of ophthalmology and the director of the Uveitis Service at the Tschannen Eye Institute. Read more about Dr. Emami-Naeini here: bit.ly/4gBcAkB
Hot off the press! Check out our latest publication on the performance of automated machine learning in retina
@JordanDeanerMD @ferhina @xephalon @ImanSoltaniPhD
Performance of automated machine learning in predicting outcomes of pneumatic retinopexy
ow.ly/cSX850QumJN
@parisaemamiMD
Parisa Emami, MD, MPH retweeted
Register for our @aao_ophth Uveitis Webinar. Case-based discussion including #uveitis trials: FAST, MUST, POINT & MERIT, w/ speakers:
Nisha Acharya, MD @proctorfndn
Parisa Emami MD @ParisaEmamiMD
Douglas Jabs, MD @JohnsHopkinsSPH
Shilpa Kodati, MD @ShilpaKodati
Arjun Sood, MD
Register today - Feb 8, Fork in the Road: Deciding Which #Uveitis Treatment Is Best, a case-based webinar looking at studies guiding the treatment of uveitis. #CME Free for Academy members #Ophthalmology ow.ly/R0WB50Qli3e
Parisa Emami, MD, MPH retweeted
Register today - Feb 8, Fork in the Road: Deciding Which #Uveitis Treatment Is Best, a case-based webinar looking at studies guiding the treatment of uveitis. #CME Free for Academy members #Ophthalmology ow.ly/R0WB50Qli3e
Check our latest 📚in @AAOjournal on disparities in ophthalmology clinical trials. More needs to be done to ensure inclusivity and generalizability🌟
@FatemeMonta3eri @ucd_eyecenter @NatEyeInstitute #ophthalmology #InclusionMatters
ophthalmologyscience.org/art…
Join us tomorrow to talk about uveitis emergencies and disasters! #aao2023 @SArepalliMD @profnidasen @ucd_eyecenter @YoungUveitis @UveitisSociety
Looking forward to discussing cases with the great faculty tonight!
📢 Join us for the Virtual Grand Rounds on Oct 4th, 8-9 PM EST 🌟
🔍 To submit cases email [email protected] by 10/1/23
@SArepalliMD @ShilpaKodati @ucd_eyecenter @EmoryEyeCenter @YoungUveitis @UveitisSociety #MedicalEducation #Uveitis #Ophthotwitter
📢 Join us for the Virtual Grand Rounds on Oct 4th, 8-9 PM EST 🌟
🔍 To submit cases email [email protected] by 10/1/23
@SArepalliMD @ShilpaKodati @ucd_eyecenter @EmoryEyeCenter @YoungUveitis @UveitisSociety #MedicalEducation #Uveitis #Ophthotwitter
Parisa Emami, MD, MPH retweeted
[REGISTRATION OPEN] Don’t miss your chance to earn #CME credit with this upcoming live-virtual symposium! KOL KNOCKOUT™: Retina Edition - Challenging Cases & Expert Opinions - Round 1. Register here: bit.ly/3EzCAv5
Parisa Emami, MD, MPH retweeted
A vascular syphilitic iris lesion
sciencedirect.com/science/ar…
ALT Initial presentation demonstrating vascular iris lesion at pupillary border (white arrow) associated with posterior synechiae (asterisk), as well as the presence of granulomatous keratic precipitates (yellow arrows)
ALT A) Anterior segment OCT through the lesion demonstrated a nodular mass with presumed superficial (arrows) and deep vascular-appearing structures (asterisk). B) Ultrasound biomicroscopy revealed a solid, echodense lesion, with relative hyperechogenicity in the anterior portion of the lesion (asterisk), and diffuse areas of small circular hypoechoic structures (white arrows) that may be vascular in nature
Join us on 6/8/23 for another evening of challenging uveitis cases and live discussion. Have a case to discuss? email us at [email protected]
@SArepalliMD @arthivenkatmd @UveitisSociety @YoungUveitis @ucd_eyecenter @EmoryEyeCenter #ophthalmology
Looking forward to these informative sessions! @YoungMDConnect @ucd_eyecenter
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
Check out these presentations and sessions by our team @ucd_eyecenter #ARVO2023 @FatemeMonta3eri
Parisa Emami, MD, MPH retweeted
Our YUS Grand Rounds held with @uveitissociety panelists is happening tonight, March 9, 8-9 PM EST (5-6 PM PST)!
Drs. Nisha Acharya @proctorfndn, JP Dunn @Wills_Eye & Meghan Berkenstock @HopkinsMedicine will serve as our expert panelists.
Register here: eeds.com/portal_recurring_ev…
Parisa Emami, MD, MPH retweeted
A successful @aao_ophth webinar! "Here Comes the SUN: The 2023 Update on Uveitis"
Organized by Chris Henry, MD
Moderators: Parisa Emami, MD & Lana Rifkin, MD
Presenters: Jennifer Cao, MD, Sapna Gangaputra, MD MPH, Edmund Tsui, MD, & Jessica Weinstein, MD
Parisa Emami, MD, MPH retweeted
Register for now our @aao_ophth #uveitis webinar this Thursday, February 9, 8:30 - 10:00pm ET.
Topics include:
✅Anatomic location of uveitis
✅Grading of cells & haze
✅Granulomatous vs non-granulomatous
✅Onset, duration, & course
Last call: #Uveitis #CME webinar on Thursday, Feb. 9, 8:30 – 10 p.m. ET. Stay up to date on the latest standardized uveitis nomenclature (SUN) as experts discuss the grading of cells and haze, granulomatous versus non-granulomatous and more. ow.ly/OpA250MG7Rz
Parisa Emami, MD, MPH retweeted
Here Comes the SUN: The 2023 Update on Uveitis store.aao.org/here-comes-the…
Join us on Thursday, Feb 9, 8:30-10PM ET
Topics covered in this @aao_ophth webinar:
➡️Anatomic location of #uveitis
➡️Grading of cells & haze
➡️Granulomatous vs non-granulomatous
➡️Onset, duration, & course